Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
5m agoHovnanian Enterprises Reports Fiscal 2026 Second Quarter Results
6m agoLivaNova Appoints Stefano Folli to Lead its Cardiopulmonary Business Unit
6m agoKKR Sells CIRCOR Aerospace to Parker Hannifin for $2.55 Billion
6m agoCosmos Health Reports Q1 2026 Results: Revenue Up 31% to $17.9M, New Q1 Record; Total Liabilities Reduced by $4.5M; Stockholders' Equity Up 7.6%; Cash of $2.2M; Record Momentum Continues into Q2 with U.S. Expansion Underway
7m agoIntuitive Announces Innovations to Advance Quintuple Aim
Ptc Therapeutics, Inc. logo

Ptc Therapeutics, Inc.

About

71.02USD+0.71 +1.01%
Closed • Updated at 13:22 GMT+00:00
Market Cap$5.89B
Volume1.09M
Beta0.37
RSI52.36
Gross Margin88.55%
Health TechnologyPharmaceuticals: Major

Ptc Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

May 7 2026
PTC Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results
May 4 2026
Ardena Strengthens Executive Team to Drive its Next Phase of Growth
Apr 28 2026
PTC Therapeutics Reports Positive Topline Results from Month 24 Interim Analysis of PIVOT-HD Extension Study of Votoplam
Apr 22 2026
PTC Therapeutics to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026
Mar 25 2026
PTC Therapeutics Appoints Biotech Banking Pioneer Jessica Chutter to Board of Directors

Community Chat

Ask AI

6ix6ixAIEvents